These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 234915)

  • 41. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.
    Waag DM; McKee KT; Sandstrom G; Pratt LL; Bolt CR; England MJ; Nelson GO; Williams JC
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):143-8. PubMed ID: 7697521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
    Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
    Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis.
    Hotta A; Uda A; Fujita O; Tanabayashi K; Yamada A
    Clin Vaccine Immunol; 2007 Jan; 14(1):81-4. PubMed ID: 17121981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.
    Musher D; Goree A; Murphy T; Chapman A; Zahradnik J; Apicella M; Baughn R
    J Infect Dis; 1986 Dec; 154(6):935-43. PubMed ID: 3491165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a safranin-O-stained antigen microagglutination test for francisella tularensis antibodies.
    Brown SL; McKinney FT; Klein GC; Jones WL
    J Clin Microbiol; 1980 Feb; 11(2):146-8. PubMed ID: 6153660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhodococcus equi: equine neutrophil chemiluminescent and bactericidal responses to opsonizing antibody.
    Martens RJ; Martens JG; Renshaw HW; Hietala SK
    Vet Microbiol; 1987 Aug; 14(3):277-86. PubMed ID: 3672870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevalence of antibodies against Francisella tularensis in Castilla y León (Spain) before 1997].
    Gutiérrez MP; Orduña A; Dueñas A; Bratos MA; Almaraz A; Alamo R; Rodríguez Recio MJ; Rodríguez Marcos H; Rodríguez Torres A
    Med Clin (Barc); 2003 Feb; 120(3):97-8. PubMed ID: 12605730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
    Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR
    J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus.
    Karakawa WW; Young DA
    Infect Immun; 1979 Jul; 25(1):175-86. PubMed ID: 478633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.
    Waag DM; Galloway A; Sandstrom G; Bolt CR; England MJ; Nelson GO; Williams JC
    J Clin Microbiol; 1992 Sep; 30(9):2256-64. PubMed ID: 1400988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of serum and lung extracts for surveys of wild animals for antibodies to Francisella tularensis biovar palaearctica.
    Mörner T; Sandström G; Mattsson R
    J Wildl Dis; 1988 Jan; 24(1):10-4. PubMed ID: 3280838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental infection of five species of raptors and of hooded crows with Francisella tularensis biovar palaearctica.
    Mörner T; Mattsson R
    J Wildl Dis; 1988 Jan; 24(1):15-21. PubMed ID: 3280839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies.
    Parthasarathy N; Saksena R; Kováč P; Deshazer D; Peacock SJ; Wuthiekanun V; Heine HS; Friedlander AM; Cote CK; Welkos SL; Adamovicz JJ; Bavari S; Waag DM
    Carbohydr Res; 2008 Nov; 343(16):2783-8. PubMed ID: 18558401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The determination of the antigenic determinant of protective monoclonal antibodies specific to the Francisella tularensis lipopolysaccharide].
    Khlebnikov VS; Golovlev IR; Tokhtamysheva NV; Averin SF; Kulevatskiĭ DP; Grechko GK; Averina AA; Vetchinin SS
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):83-8. PubMed ID: 7520655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-mediated immunity against Francisella tularensis after natural infection.
    Koskela P; Herva E
    Scand J Infect Dis; 1980; 12(4):281-7. PubMed ID: 7006062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.